Education
About Us
Working with TipRanks
Follow Us
OrthoPediatrics Corp (KIDS)
NASDAQ:KIDS
Total Valuation
OrthoPediatrics has a market cap or net worth of $568.45M. The enterprise value is $527.58M.
Market Cap$568.45M
Enterprise Value$527.58M
Share Statistics
OrthoPediatrics has 24,769,049 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding24,769,049
Owned by Insiders32.79%
Owned by Institutions25.57%
Financial Efficiency
OrthoPediatrics’s return on equity (ROE) is -0.11 and return on invested capital (ROIC) is -6.06%.
Return on Equity (ROE)-0.11
Return on Assets (ROA)-0.08
Return on Invested Capital (ROIC)-6.06%
Return on Capital Employed (ROCE)-0.07
Revenue Per Employee364.28K
Profits Per Employee-67.30K
Employee Count562
Asset Turnover0.43
Inventory Turnover0.48
Valuation Ratios
The current PE Ratio of OrthoPediatrics is -14.14. OrthoPediatrics’s PEG ratio is 0.41.
PE Ratio-14.14
PS Ratio0.00
PB Ratio1.44
Price to Fair Value1.51
Price to FCF-13.14
Price to Operating Cash Flow-18.64
PEG Ratio0.41
Income Statement
In the last 12 months, OrthoPediatrics had revenue of 204.73M and earned -37.82M in profits. Earnings per share was -1.64.
Revenue204.73M
Gross Profit148.60M
Operating Income-29.52M
Pretax Income-41.93M
Net Income-37.82M
EBITDA-10.44M
Earnings Per Share (EPS)-1.64
Cash Flow
In the last 12 months, operating cash flow was -27.39M and capital expenditures -14.26M, giving a free cash flow of -41.65M billion.
Operating Cash Flow-27.39M
Free Cash Flow-41.65M
Free Cash Flow per Share-1.68
Dividends & Yields
OrthoPediatrics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.86
52-Week Price Change-29.45%
50-Day Moving Average23.00
200-Day Moving Average25.30
Relative Strength Index (RSI)54.65
Average Volume (3m)152.18K
Important Dates
OrthoPediatrics upcoming earnings date is Jul 30, 2025, TBA Not Confirmed.
Last Earnings DateMay 7, 2025
Next Earnings DateJul 30, 2025
Ex-Dividend Date―
Financial Position
OrthoPediatrics as a current ratio of 6.98, with Debt / Equity ratio of 6.80%
Current Ratio6.98
Quick Ratio3.54
Debt to Market Cap0.05
Net Debt to EBITDA1.89
Interest Coverage Ratio-11.26
Taxes
In the past 12 months, OrthoPediatrics has paid -4.11M in taxes.
Income Tax-4.11M
Effective Tax Rate0.10
Enterprise Valuation
OrthoPediatrics EV to EBITDA ratio is -49.35, with an EV/FCF ratio of -12.47.
EV to Sales2.52
EV to EBITDA-49.35
EV to Free Cash Flow-12.47
EV to Operating Cash Flow-19.05
Balance Sheet
OrthoPediatrics has $68.83M in cash and marketable securities with $24.12M in debt, giving a net cash position of -$44.72M billion.
Cash & Marketable Securities$68.83M
Total Debt$24.12M
Net Cash-$44.72M
Net Cash Per Share-$1.81
Tangible Book Value Per Share$8.51
Margins
Gross margin is 67.79%, with operating margin of -14.42%, and net profit margin of -18.47%.
Gross Margin67.79%
Operating Margin-14.42%
Pretax Margin-20.48%
Net Profit Margin-18.47%
EBITDA Margin-5.10%
EBIT Margin-14.42%
Analyst Forecast
The average price target for OrthoPediatrics is $36.43, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$36.43
Price Target Upside58.74% Upside
Analyst ConsensusStrong Buy
Analyst Count7
Revenue Growth Forecast31.28%
EPS Growth Forecast-81.86%